Back

Implantation of human iPS cell-derived engineered cardiac tissues including cardiomyocytes and multiple vascular lineages ameliorates cardiac dysfunction after myocardial infarction in a rat model

29 August 2016 (08:30 - 12:30)
Organised by:
Congress Presentation Part of: Poster session 4 - Cell and gene therapy Stem cells and cell therapy ESC Premium Access ESC Congress 2016

About the speaker

Photo
Doctor Hidetoshi Masumoto

Kansai Medical University, Osaka (Japan)

15 More presentations in this session

Presentation thumbnail
Doctor S. Ghadge (Vienna, AT)
Abstract Slides
Presentation thumbnail
Doctor Y. Liu (New Taipei, TW)
Abstract
Presentation thumbnail
Associate Professor J. Oh (Seoul, KR)
Abstract
Presentation thumbnail
Doctor E. Gara (Budapest, HU)
Abstract
Presentation thumbnail
Doctor O. Inoue (Kanazawa, JP)
Abstract Slides

Access the full session

Session thumbnail
Poster session 4 - Cell and gene therapy

The Event

Event poster

ESC Congress 2016

29 August 2016 08:30 CET
You may be interested in
thumbnail
Webinar
Induced-pluripotent stem cells (iPSC) technology for cardiac repair
17 March 2022
thumbnail
Congress Presentation
Extracellular vesicles derived from hyaluronic acid primed induced pluripotent stem cell derived mesenchymal stem cell can ameliorate the heart function.
20 May 2023
thumbnail
Congress Presentation
Scalable and stable human pluripotent stem cell-derived microvascular-like endothelial cells for cardiac regeneration and disease modelling applications.
26 August 2023
thumbnail
Congress Presentation
Safety and efficacy of induced pluripotent stem cell-derived engineered human myocardium as biological ventricular assist tissue in term. heart failure (BioVAT-HF):trial design and experience at UKSH
21 May 2023

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources